Proposed study focuses on Youth With HIV (YWH) recruited from the University of North Carolina using a cross sectional assessment of blood samples, clinical, demographic, behavioral, \[including substance use and frequency\], and neurocognitive data will be evaluated from YWH treated before CD4 T cell decline.
The long-term goal for the proposed research is to apply a systems biology approach to discover evidence that provides the basis for understanding the complex and at times conflicting roles for marijuana in chronic inflammation in HIV-infected youth. To achieve the goal, a systems biology approach with two aims is designed: Aim 1. To identify inflammatory immune pathways perturbed by recreational marijuana with or without concomitant use of tobacco products by applying a deep sequencing approach to define global transcriptome of peripheral blood cells from HIV-infected virally suppressed youth. Aim 2. To develop biomarker profiles associated with pro- or anti-inflammatory pathways perturbed by marijuana and to discover biomarker profiles linked to neurocognitive impairment that are impacted by marijuana and tobacco use by YWH
Study Type
OBSERVATIONAL
Enrollment
21
Duke UMC
Durham, North Carolina, United States
Duke University Medical Center
Durham, North Carolina, United States
Number of bio-marker pathways that are abnormal.
This is measured by molecular mechanism of chronic macrophage activation.
Time frame: 24 months
Plasma levels of sCD163
Chi-square test will be used to compare discrete variables
Time frame: 24 months
Neurocognitive function as measured by Trial Making Test (TMT)
Time frame: 24 months
Neurocognitive function as measured by WAIS-III (5 subtest IQ estimate)
Time frame: 24 months
Neurocognitive function as measured by Hopkins Verbal Learning Test-R
Time frame: 24 months
Neurocognitive function as measured by the Brief Visuospatial Memory Test-R
Time frame: 24 months
Neurocognitive function as measured by the WRAT-4 Word Reading subtest
Time frame: 24 months
Neurocognitive function as measured by Activities of Daily Living Questionnaire
Time frame: 24 months
Neurocognitive function as measured by Behavior Rating Inventory of Executive Functioning
Time frame: 24 months
Neurocognitive function as measured by Grooved Pegboard test
Time frame: 24 months
Neurocognitive function as measured by Timed Gait Test
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Time frame: 24 months
Neurocognitive function as measured by Verbal Fluency Test
Time frame: 24 Months
Neurocognitive function as measured by Brief Symptom Inventory
Time frame: 24 months
Neurocognitive function as measured by Beck Depression Inventory-II
Time frame: 24 months
Neurocognitive function as measured by ASSIST (substance abuse)
Time frame: 24 months
Neurocognitive function as measured by Base ATN Adherence Questions
Time frame: 24 months